1. FDA grants Bristol-Myers priority review for ide-cel — Is Illumina making an $8B blunder? — Medicare may not cover the cost of the coronavirus vaccine — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Accera

Discussion in 'Neurology' started by Anonymous, Mar 23, 2010 at 11:18 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    What is going on with this co? Are they going to expand?
     

  2. Anonymous

    Anonymous Guest

    No expansion. Just cut 50% of salesforce. I just got laid-off
     
  3. Anonymous

    Anonymous Guest

    Yeah, me too....no study, no marketing, no patient education...what a poor excuse for a company.
     
  4. Anonymous

    Anonymous Guest

    Whatever happened to this company?
     
  5. Anonymous

    Anonymous Guest

    Heard they are re-launching Axona...thoughts?